Biomarkers in Alzheimer's and Parkinson's Diseases for IA
NCT: NCT07651085 · ACTIVE_NOT_RECRUITING
Brief Summary
Investigate whether endogenous and exogenous risk factors, the presence of pathological amyloid aggregates and alpha-synuclein in the CSF, brain connectivity, and some clinical and biological indices such as vigilance, general motility, the sleep-wake cycle, genomic instability and possible DNA damage may correlate with (or predict) the clinical condition of mild cognitive impairment (MCI) and dementia in patients with Alzheimer's disease (AD) and Parkinson's disease (PD).
Frequently Asked Questions
What is Biomarkers in Alzheimer's and Parkinson's Diseases for IA?
Biomarkers in Alzheimer's and Parkinson's Diseases for IA is a clinical trial registered under NCT07651085. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07651085?
The current status of NCT07651085 (Biomarkers in Alzheimer's and Parkinson's Diseases for IA) is: ACTIVE_NOT_RECRUITING.
When did Biomarkers in Alzheimer's and Parkinson's Diseases for IA start?
Biomarkers in Alzheimer's and Parkinson's Diseases for IA started on 2024-02-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.